BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29702185)

  • 21. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation.
    Yao S; Huang HY; Han X; Ye Y; Qin Z; Zhao G; Li F; Hu G; Hu L; Ji H
    Oncogene; 2019 Sep; 38(36):6354-6369. PubMed ID: 31320708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
    Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.
    Cha YJ; Kim HR; Lee CY; Cho BC; Shim HS
    Lung Cancer; 2016 Jul; 97():73-80. PubMed ID: 27237031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis.
    Lahtela J; Pradhan B; Närhi K; Hemmes A; Särkioja M; Kovanen PE; Brown A; Verschuren EW
    Dis Model Mech; 2015 Apr; 8(4):393-401. PubMed ID: 25713296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells].
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Shen X; Li S; Liang Y; Liu M; Yang Z
    Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):427-35. PubMed ID: 26182868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.
    Nakano T; Kanai Y; Amano Y; Yoshimoto T; Matsubara D; Shibano T; Tamura T; Oguni S; Katashiba S; Ito T; Murakami Y; Fukayama M; Murakami T; Endo S; Niki T
    PLoS One; 2017; 12(8):e0181342. PubMed ID: 28786996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.
    Wang Y; Hou N; Cheng X; Zhang J; Tan X; Zhang C; Tang Y; Teng Y; Yang X
    Int J Biol Sci; 2017; 13(5):652-659. PubMed ID: 28539837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis.
    Rau KM; Chen HK; Shiu LY; Chao TL; Lo YP; Wang CC; Lin MC; Huang CC
    Int J Mol Sci; 2016 Apr; 17(4):524. PubMed ID: 27070580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
    Zhou LN; Li SC; Li XY; Ge H; Li HM
    Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas.
    Li J; Sordella R; Powers S
    Sci Rep; 2016 Jun; 6():27891. PubMed ID: 27301828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-Cadherin Loss Accelerates Tumor Progression and Metastasis in a Mouse Model of Lung Adenocarcinoma.
    Sinkevicius KW; Bellaria KJ; Barrios J; Pessina P; Gupta M; Brainson CF; Bronson RT; Kim CF
    Am J Respir Cell Mol Biol; 2018 Aug; 59(2):237-245. PubMed ID: 29447458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma.
    Castro IC; Breiling A; Luetkenhaus K; Ceteci F; Hausmann S; Kress S; Lyko F; Rudel T; Rapp UR
    Mol Cancer Res; 2013 Feb; 11(2):161-72. PubMed ID: 23239811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
    Choi H; Kratz J; Pham P; Lee S; Ray R; Kwon YW; Mao JH; Kang HC; Jablons D; Kim IJ
    Int J Oncol; 2012 Jun; 40(6):1900-6. PubMed ID: 22407457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression.
    Wu YH; Wu TC; Liao JW; Yeh KT; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10422-32. PubMed ID: 21056989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Overexpression of p21WAF1 and p53 in human lung adenocarcinoma cell line].
    Wu Y; Yan CH; Jin Y; Zhang GY; Li P; Fu SB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):149-52. PubMed ID: 12905708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression.
    Bhinge K; Yang L; Terra S; Nasir A; Muppa P; Aubry MC; Yi J; Janaki N; Kovtun IV; Murphy SJ; Halling G; Rahi H; Mansfield A; de Andrade M; Yang P; Vasmatzis G; Peikert T; Kosari F
    Oncotarget; 2017 Apr; 8(16):27155-27165. PubMed ID: 28460442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.